• Professor, Surgery, CWRU School of Medicine

Education & Training


1992, Vanderbilt University

Medical / Professional School(s)

1997, Keck Medical Center of USC (Keck Hospital of USC)


1998, General Surgery - Massachusetts General Hospital


2004, General Surgery - Massachusetts General Hospital


2005, Laparoscopic Surgery - Carolinas Medical Center

Research Fellowship

2002, Minimally Invasive Surgery - Cleveland Clinic


Gastrointestinal Surgery, Gastrointestional Cancer, Hernia Surgery, Laparoscopic and Minimally Invasive Surgery, Upper Gastrointestinal Cancer

Selected Publications

Preoperative Chlorhexidine Gluconate Use May Increase Risk for Surgical Site Infections after Ventral Hernia Repair.
Prabhu AS, Krpata DM, Phillips S, Huang LC, Haskins IN, Rosenblatt S, Poulose BK, Rosen MJ

Multicenter, Prospective, Longitudinal Study of the Recurrence, Surgical Site Infection, and Quality of Life After Contaminated Ventral Hernia Repair Using Biosynthetic Absorbable Mesh: The COBRA Study.
Rosen MJ, Bauer JJ, Harmaty M, Carbonell AM, Cobb WS, Matthews B, Goldblatt MI, Selzer DJ, Poulose BK, Hansson BM, Rosman C, Chao JJ, Jacobsen GR

Response to Letter to The Editor Regarding the COBRA Trial: What Will it Take to Perform High-quality Hernia Research?
Rosen MJ

Antibiotic-releasing microspheres prevent mesh infection in vivo.
Grafmiller KT, Zuckerman ST, Petro C, Liu L, von Recum HA, Rosen MJ, Korley JN

Development of a Disease-based Hernia Program and the Impact on Cost for a Hospital System.
Krpata DM, Haskins IN, Rosenblatt S, Grundfest S, Prabhu A, Rosen MJ

Does Preoperative Bowel Preparation Reduce Surgical Site Infections During Elective Ventral Hernia Repair?
Krpata DM, Haskins IN, Phillips S, Prabhu AS, Rosenblatt S, Poulose BK, Rosen MJ

A Low Neutrophil CD64 Index Is Associated with Sustained Remission During Infliximab Maintenance Therapy.
Minar P, Jackson K, Tsai YT, Rosen MJ, Northcutt M, Khodoun M, Finkelman FD, Denson LA

Arteriovenous loop graft in abdominal wall reconstruction using free tissue transfer.
Gurunluoglu R, Ghaznavi A, Krpata D, Zins J, Rosen MJ

Intra-Abdominal Hypertension and Abdominal Compartment Syndrome after Abdominal Wall Reconstruction: Quaternary Syndromes?
Kirkpatrick AW, Nickerson D, Roberts DJ, Rosen MJ, McBeth PB, Petro CC, Berrevoet F, Sugrue M, Xiao J, Ball CG

Laparoscopic versus open inguinal hernia repair in patients with obesity: an American College of Surgeons NSQIP clinical outcomes analysis.
Froylich D, Haskins IN, Aminian A, O'Rourke CP, Khorgami Z, Boules M, Sharma G, Brethauer SA, Schauer PR, Rosen MJ

View All Publications

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2015, Michael Rosen, MD disclosed the following Outside Relationships with Industry:

Davol - Consulting

LifeCell - Consulting

There is no publicly available rating for this medical professional for one of two reasons: 1) he or she does not see patients or 2) he or she sees patients but has not yet received the minimum number of Patient Satisfaction Reviews. To be eligible for display, we require a minimum of 30 surveys. This ensures that the rating is statistically reliable and a true reflection of patient satisfaction.